EPG5
Basic information
Region (hg38): 18:45800581-45967329
Previous symbols: [ "KIAA1632" ]
Links
Phenotypes
GenCC
Source:
- Vici syndrome (Definitive), mode of inheritance: AR
- Vici syndrome (Strong), mode of inheritance: AR
- Vici syndrome (Strong), mode of inheritance: AR
- Vici syndrome (Supportive), mode of inheritance: AR
- Vici syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Vici syndrome | AR | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular | Antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; Surveillance for cardiomyopathy (eg, including echocardiogram) may allow early management; Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic | 20186778; 23222957; 27343256; 28168853 |
ClinVar
This is a list of variants' phenotypes submitted to
- Vici_syndrome (2155 variants)
- Inborn_genetic_diseases (330 variants)
- not_provided (230 variants)
- EPG5-related_disorder (81 variants)
- not_specified (30 variants)
- Microcephaly (3 variants)
- Limb-girdle_muscular_dystrophy (2 variants)
- Syndromic_retinitis_pigmentosa (2 variants)
- Intellectual_disability (2 variants)
- Global_developmental_delay (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EPG5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000020964.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 718 | 17 | 742 | |||
| missense | 869 | 57 | 12 | 947 | ||
| nonsense | 64 | 22 | 92 | |||
| start loss | 1 | 1 | 2 | |||
| frameshift | 68 | 13 | 86 | |||
| splice donor/acceptor (+/-2bp) | 23 | 33 | ||||
| Total | 139 | 69 | 890 | 775 | 29 |
Highest pathogenic variant AF is 0.000028214687
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| EPG5 | protein_coding | protein_coding | ENST00000282041 | 44 | 119667 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.35e-13 | 1.00 | 124715 | 0 | 112 | 124827 | 0.000449 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.08 | 1233 | 1.34e+3 | 0.917 | 0.0000699 | 16923 |
| Missense in Polyphen | 598 | 690.76 | 0.86571 | 9074 | ||
| Synonymous | -0.950 | 548 | 520 | 1.05 | 0.0000282 | 4979 |
| Loss of Function | 6.88 | 48 | 134 | 0.358 | 0.00000684 | 1556 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00131 | 0.00124 |
| Ashkenazi Jewish | 0.0000993 | 0.0000993 |
| East Asian | 0.000564 | 0.000556 |
| Finnish | 0.000140 | 0.000139 |
| European (Non-Finnish) | 0.000454 | 0.000450 |
| Middle Eastern | 0.000564 | 0.000556 |
| South Asian | 0.000327 | 0.000327 |
| Other | 0.000496 | 0.000495 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in autophagy. May play a role in a late step of autophagy, such as clearance of autophagosomal cargo. {ECO:0000269|PubMed:20550938, ECO:0000269|PubMed:23222957}.;
- Disease
- DISEASE: Vici syndrome (VICIS) [MIM:242840]: A rare congenital multisystem disorder characterized by agenesis of the corpus callosum, cataracts, pigmentary defects, progressive cardiomyopathy, and variable immunodeficiency. Affected individuals also have profound psychomotor retardation and hypotonia due to a myopathy. {ECO:0000269|PubMed:23222957}. Note=The disease is caused by mutations affecting the gene represented in this entry. Affected individuals show homozygosity or compound heterozygosity for truncating mutations, aberrant splicing and/or missense mutations. Parental studies suggest recessive inheritance with no carrier manifestation (PubMed:23222957). {ECO:0000269|PubMed:23222957}.;
Recessive Scores
- pRec
- 0.0999
Intolerance Scores
- loftool
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 28.31
Haploinsufficiency Scores
- pHI
- 0.228
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.554
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Epg5
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; cellular phenotype; immune system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; muscle phenotype;
Gene ontology
- Biological process
- autophagy;autophagosome maturation
- Cellular component
- cytoplasm
- Molecular function